White Papers

  1. High-Volume Manufacturing: Essential Points To Consider Before You Scale Up

    To successfully scale to high-volume manufacturing, planning is required for streamlining the production process and minimizing the changes that could add unnecessary time and expense to the process. This white paper addresses critical points to keep in mind early in the medical device life cycle.

  2. BioProcess Containers – Materials Of Construction

    Several characteristics are important to the performance of BPCs, including biological compatibility, physical and mechanical properties, and extractables and leachables (E&L).

  3. How Much Will Your Pharmaceutical Powder Screw Feeder Cost?

    An efficient feeding system can offer significant return on investment thanks to higher accuracy and better control, despite the higher initial capital investment.

  4. The Case For A Facility Monitoring System

    The business benefits of installing a facility monitoring system.

  5. Inspecting On The Edge – Understanding Punch Tip Wear

    Avoid production quality-related issues by understanding and knowing how to identify the most common causes of punch tip edge wear.

  6. Tool Life Expectancy

    How to maintain the integrity of your tools and ensure consistent and efficient table manufacturing.

  7. Aggregation – Solutions For The Traceability Of Products

    Explaining aggregation process in serialization applications.

  8. Enhancing Process Safety In The Pharmaceutical Industry

    This paper focuses on how to enhance a pharmaceutical production facility's process safety with a dynamic checkweighing system.

  9. Accelerate Your Process Development With High-Throughput, Single-Use, Fully Automated Bioreactors

    Biopharmaceutical R&D teams everywhere face the same dilemma in the development of biologics and vaccines: they must increase productivity to meet strict budgets and deadlines, while maintaining or improving data accuracy.

  10. Advances In Single-Use Technologies For Cell Clarification

    One of the major challenges in batch mammalian cell clarification is cost-effective improvement in filtration in the face of high cell densities. Single-use technology has serious benefits for flexibility in production, pilot or clinical batches, but with existing filtration equipment, the economic benefits have not been fully realized at volumes < 2,000 liters. Developers and CMOs alike require cell clarification technology that offers higher yields, fewer failures, and the ease of use of single-use, with reduced consumables costs for cost-effective drug development and production.